IBDEI3HS ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,58728,2)
 ;;=^265435
 ;;^UTILITY(U,$J,358.3,58729,0)
 ;;=H50.52^^272^2911^7
 ;;^UTILITY(U,$J,358.3,58729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58729,1,3,0)
 ;;=3^Exophoria
 ;;^UTILITY(U,$J,358.3,58729,1,4,0)
 ;;=4^H50.52
 ;;^UTILITY(U,$J,358.3,58729,2)
 ;;=^265436
 ;;^UTILITY(U,$J,358.3,58730,0)
 ;;=H51.11^^272^2911^4
 ;;^UTILITY(U,$J,358.3,58730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58730,1,3,0)
 ;;=3^Convergence Insufficiency
 ;;^UTILITY(U,$J,358.3,58730,1,4,0)
 ;;=4^H51.11
 ;;^UTILITY(U,$J,358.3,58730,2)
 ;;=^5006251
 ;;^UTILITY(U,$J,358.3,58731,0)
 ;;=H51.12^^272^2911^3
 ;;^UTILITY(U,$J,358.3,58731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58731,1,3,0)
 ;;=3^Convergence Excess
 ;;^UTILITY(U,$J,358.3,58731,1,4,0)
 ;;=4^H51.12
 ;;^UTILITY(U,$J,358.3,58731,2)
 ;;=^5006252
 ;;^UTILITY(U,$J,358.3,58732,0)
 ;;=H53.033^^272^2911^11
 ;;^UTILITY(U,$J,358.3,58732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58732,1,3,0)
 ;;=3^Strabismic Amblyopia,Bilateral
 ;;^UTILITY(U,$J,358.3,58732,1,4,0)
 ;;=4^H53.033
 ;;^UTILITY(U,$J,358.3,58732,2)
 ;;=^5006305
 ;;^UTILITY(U,$J,358.3,58733,0)
 ;;=H53.032^^272^2911^12
 ;;^UTILITY(U,$J,358.3,58733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58733,1,3,0)
 ;;=3^Strabismic Amblyopia,Left Eye
 ;;^UTILITY(U,$J,358.3,58733,1,4,0)
 ;;=4^H53.032
 ;;^UTILITY(U,$J,358.3,58733,2)
 ;;=^5006304
 ;;^UTILITY(U,$J,358.3,58734,0)
 ;;=H53.031^^272^2911^13
 ;;^UTILITY(U,$J,358.3,58734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58734,1,3,0)
 ;;=3^Strabismic Amblyopia,Right Eye
 ;;^UTILITY(U,$J,358.3,58734,1,4,0)
 ;;=4^H53.031
 ;;^UTILITY(U,$J,358.3,58734,2)
 ;;=^5006303
 ;;^UTILITY(U,$J,358.3,58735,0)
 ;;=D86.83^^272^2912^20
 ;;^UTILITY(U,$J,358.3,58735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58735,1,3,0)
 ;;=3^Sarcoid Iridocyclitis
 ;;^UTILITY(U,$J,358.3,58735,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,58735,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,58736,0)
 ;;=H53.71^^272^2912^7
 ;;^UTILITY(U,$J,358.3,58736,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58736,1,3,0)
 ;;=3^Glare Sensitivity
 ;;^UTILITY(U,$J,358.3,58736,1,4,0)
 ;;=4^H53.71
 ;;^UTILITY(U,$J,358.3,58736,2)
 ;;=^5006354
 ;;^UTILITY(U,$J,358.3,58737,0)
 ;;=H53.72^^272^2912^9
 ;;^UTILITY(U,$J,358.3,58737,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58737,1,3,0)
 ;;=3^Impaired Contrast Sensitivity
 ;;^UTILITY(U,$J,358.3,58737,1,4,0)
 ;;=4^H53.72
 ;;^UTILITY(U,$J,358.3,58737,2)
 ;;=^5006355
 ;;^UTILITY(U,$J,358.3,58738,0)
 ;;=H57.13^^272^2912^14
 ;;^UTILITY(U,$J,358.3,58738,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58738,1,3,0)
 ;;=3^Ocular Pain,Bilateral
 ;;^UTILITY(U,$J,358.3,58738,1,4,0)
 ;;=4^H57.13
 ;;^UTILITY(U,$J,358.3,58738,2)
 ;;=^5006384
 ;;^UTILITY(U,$J,358.3,58739,0)
 ;;=H57.11^^272^2912^16
 ;;^UTILITY(U,$J,358.3,58739,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58739,1,3,0)
 ;;=3^Ocular Pain,Right Eye
 ;;^UTILITY(U,$J,358.3,58739,1,4,0)
 ;;=4^H57.11
 ;;^UTILITY(U,$J,358.3,58739,2)
 ;;=^5006382
 ;;^UTILITY(U,$J,358.3,58740,0)
 ;;=H57.12^^272^2912^15
 ;;^UTILITY(U,$J,358.3,58740,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58740,1,3,0)
 ;;=3^Ocular Pain,Left Eye
 ;;^UTILITY(U,$J,358.3,58740,1,4,0)
 ;;=4^H57.12
 ;;^UTILITY(U,$J,358.3,58740,2)
 ;;=^5006383
 ;;^UTILITY(U,$J,358.3,58741,0)
 ;;=I10.^^272^2912^8
 ;;^UTILITY(U,$J,358.3,58741,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58741,1,3,0)
 ;;=3^Hypertension,Essential
 ;;^UTILITY(U,$J,358.3,58741,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,58741,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,58742,0)
 ;;=L71.9^^272^2912^19
